Back to Search
AXEL GROTHEY, M.D.
M.D.
Hematology & Oncology Physician
NPI: 1841278678IndividualAccepts Medicare
Specialties, Licenses & Credentials
Hematology & Oncology PhysicianPrimary
Internal Medicine — Hematology & Oncology
Code: 207RH0003X
58339(TN)
CMS Specialties
PrimaryHEMATOLOGY/ONCOLOGY
Education
OTHER
Class of 1987
Research & Publications (20)
Targeting angiogenesis: progress with anti-VEGF treatment with large molecules.
PMID 19636328·Nat Rev Clin Oncol·2009
6-review
Anti-angiogenic therapies for metastatic colorectal cancer.
PMID 19588372·Cochrane Database Syst Rev·2009
1-meta
Evidence for cure by adjuvant therapy in colon cancer: observations based on individual patient data from 20,898 patients on 18 randomized trials.
PMID 19124803·J Clin Oncol·2009
8-other
Pooled safety and efficacy analysis examining the effect of performance status on outcomes in nine first-line treatment trials using individual data from patients with metastatic colorectal cancer.
PMID 19255311·J Clin Oncol·2009
1-meta
Improved survival in metastatic colorectal cancer is associated with adoption of hepatic resection and improved chemotherapy.
PMID 19470929·J Clin Oncol·2009
4-observational
A comparison of XELOX with FOLFOX-4 as first-line treatment for metastatic colorectal cancer.
PMID 18957948·Nat Clin Pract Oncol·2009
4-observational
Chemotherapy-induced peripheral neuropathy: prevention and treatment strategies.
PMID 18571399·Eur J Cancer·2008
6-review
Bevacizumab beyond first progression is associated with prolonged overall survival in metastatic colorectal cancer: results from a large observational cohort study (BRiTE).
PMID 18854571·J Clin Oncol·2008
4-observational
Individualizing therapy for metastatic colorectal cancer.
PMID 19227569·Oncology (Williston Park)·2008
8-other
Response-independent survival benefit in metastatic colorectal cancer: a comparative analysis of N9741 and AVF2107.
PMID 18182660·J Clin Oncol·2008
4-observational
North Central Cancer Treatment Group--achievements and perspectives.
PMID 18929151·Semin Oncol·2008
6-review
Surrogate endpoints for overall survival in early colorectal cancer from the clinician's perspective.
PMID 18285442·Stat Methods Med Res·2008
8-other
Survival following recurrence in stage II and III colon cancer: findings from the ACCENT data set.
PMID 18467725·J Clin Oncol·2008
4-observational
Phase I trial of a pathotropic retroviral vector expressing a cytocidal cyclin G1 construct (Rexin-G) in patients with advanced pancreatic cancer.
PMID 18388964·Mol Ther·2008
3-trial
Efficacy of oxaliplatin plus capecitabine or infusional fluorouracil/leucovorin in patients with metastatic colorectal cancer: a pooled analysis of randomized trials.
PMID 19018087·J Clin Oncol·2008
4-observational
Improving the Odds for a Patient With Potentially Curable Stage IV Colorectal Cancer: A Question of Chemosensitivity.
PMID 19259312·Gastrointest Cancer Res·2008
5-case
Oxaliplatin in combination with 5-fluorouracil/leucovorin or capecitabine in elderly patients with metastatic colorectal cancer.
PMID 18279579·Clin Colorectal Cancer·2008
3-trial
KRAS mutation in metastatic colorectal cancer and its impact on the use of EGFR inhibitors.
PMID 19378369·Clin Adv Hematol Oncol·2008
8-other
Targeting the right target: epidermal growth factor receptor-directed individualized therapy.
PMID 18361805·Clin Colorectal Cancer·2007
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 7945 WOLF RIVER BLVD
GERMANTOWN, TN 38138 - Phone
- (901) 683-0055
Quick Facts
- NPI
- 1841278678
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 39
- Publications
- 20
Are you this provider?
Claim Your Profile